Position in INCY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$185,938,199
+$9,318,676 QoQ
Shares Held
1,975,544
+10.5% QoQ
Ownership
0.989%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 82.62929096998093.ToString("F0")%
Shared 14.03638693949616.ToString("F0")%
None 3.3343220905229143.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. INCY ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
This page
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $185,938,199 | 1,975,544 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $176,619,523 | 1,788,190 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $135,367,699 | 1,596,129 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $94,520,211 | 1,387,962 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $80,723,744 | 1,333,175 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $91,552,628 | 1,325,505 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $93,372,065 | 1,412,588 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $71,608,524 | 1,181,269 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $54,155,907 | 950,604 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $59,689,804 | 950,626 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $51,313,970 | 888,246 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $52,631,376 | 845,484 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $54,389,676 | 752,590 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $56,850,253 | 707,797 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $45,861,711 | 688,201 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $46,545,221 | 612,679 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $47,336,067 | 596,022 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $40,579,483 | 552,854 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $36,361,785 | 528,668 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $38,303,631 | 455,291 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $33,040,318 | 406,550 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,757,999 | 411,106 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $37,012,545 | 412,442 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,928,726 | 393,659 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $29,657,564 | 404,992 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||